Bausch + Lomb Corporation (BLCO) has released an update.
Bausch + Lomb Corporation, a leading eye health company, announced the immediate appointment of Karen L. Ling to its Board of Directors, coinciding with the retirement of Richard De Schutter after the 2024 Annual Meeting. Ling brings a wealth of experience in human capital management and corporate governance from her previous executive roles and board memberships. The company expressed confidence that Ling’s contributions will support Bausch + Lomb’s global growth strategy and stakeholder value creation.
For further insights into BLCO stock, check out TipRanks’ Stock Analysis page.
